BETA

5 Amendments of Notis MARIAS related to 2016/2169(DEC)

Amendment 1 #
Draft opinion
Paragraph 1
1. Recalls that, as stipulated in its financial regulation, budget revenue of the European Medicines Agency ('the Agency') is based on cash received for contributions from the Union, fees for circulation and marketing authorisation applications for pharmaceutical products and for post- authorisation activities as well as for various administrative activities;
2016/12/14
Committee: ENVI
Amendment 2 #
Proposal for a decision 1
Paragraph 1
1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency’s budget for the financial year 2015 / Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency’s budget for the financial year 2015;
2017/03/06
Committee: CONT
Amendment 4 #
Proposal for a decision 2
Paragraph 1
1. Approves the closure of the accounts of the European Medicines Agency for the financial year 2015 / Postpones the closure of the accounts of the European Medicines Agency for the financial year 2015;
2017/03/06
Committee: CONT
Amendment 14 #
Draft opinion
Paragraph 7
7. NotesDeplores the fact that in 2015 the Agency recommended 93 medicines for marketing authorisation and that those include 39 new active substances; stresses that those substances have previously never been authorised in a medicine in the Union and are not related to the chemical structure of any other authorised substance;
2016/12/14
Committee: ENVI
Amendment 24 #
Draft opinion
Paragraph 9
9. Recommends, on the basis of the facts available, that discharge be grantedpostponing discharge to the Executive Director of the European Medicines Agency with respect to the implementation of the Agency’s budget for the financial year 2015.
2016/12/14
Committee: ENVI